UNSPSC 51182007: Methandriol

This classification denotes an anabolic steroid with the molecular formula C20H32O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5730Z864KG, chemically known as 17-methylandrost-5-ene-3-beta,17-beta-diol but generally known as methandriol, which bears US NIH Compound Identifier 10632. European Medicines Agency schedules Methandriol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08835MIG. The term METHANDRIOL is an International Non-Proprietary Name.

UNSPSC 51182007 Methandriol is a Commodity code for an anabolic steroid active pharmaceutical ingredient; however, recent state and local procurement activity under this code does not reflect direct purchases of methandriol itself. Instead, the single recent opportunity shows the code being applied to a broader generic multi-source pharmaceutical supply agreement. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 for manufacturers and suppliers of generic pharmaceuticals and over-the-counter products to be distributed across participating state and local government facilities in Minnesota and Oregon. The solicitation emphasizes pricing competitiveness (weighted at 75 percent of evaluation), compliance with current Good Manufacturing Practices and Drug Supply Chain Security Act requirements, and the ability to supply products through three authorized wholesalers — AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC. Vendors must maintain substantial insurance coverage including $5 million commercial general liability per occurrence, submit detailed product information with National Drug Codes and SKUs, and agree to a 3 percent administrative fee on all contract purchases.

The cooperative purchasing vehicle and multi-state scope indicate that MMCAP itself is the primary issuing body, though the underlying customer base spans state agencies and local government facilities across at least two states. The RFP response deadline was March 26, 2026, with awarded vendors to take effect July 1, 2026, for a two-year initial contract term with optional extensions through June 30, 2028. No specific award values, budget ranges, or set-aside designations are disclosed. The mismatch between the Commodity code's nominal scope (methandriol as a single active ingredient) and the actual solicitation (a broad generic pharmaceutical supply framework) suggests limited relevance to firms specializing in methandriol or other individual pharmaceutical actives; the code's recent activity aligns instead with full-line generic pharmaceutical distribution and supply-chain partnerships.